Introduction to Medications for Opioid Use Disorder Treatment

Course overview

Course Description This Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administrationapproved medications used to treat opioid use disorder methadone, naltrexone, and buprenorphine and the other strategies and services needed to support recovery. Part One offers a general introduction to providing medications to address opioid use disorder. It presents key facts and issues related to providing FDAapproved medications used to treat opioid use disorder. This course is based upon material published in the SAMHSA Treatment Improvement Protocol 63 and is available as an open access article. This course on opioid use disorder treatment is designed for social workers, professional counselors, psychologists, nurses, and substance abuse counselors, who do clinical work. This course is appropriate for beginning, intermediate and advanced level practitioners who wish to develop their understanding of treatments for opioid use disorder. The course material includes a review of interventions. It may also be useful for licensed clinicians who require clinical continuing education courses for license renewal. Authors Substance Abuse and Mental Health Services Administration, a division of the United States Department of Health and Human Services Learning Objectives This course will provide the practitioner with detailed information regarding medications used to treat opioid use disorder. Specifically, a professional will Describe the public costs related to opioid use Identify who can prescribe the different approved opioid medications Recognize the risks and benefits of using each of the approved medications Citation Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol TIP Series 63, Executive Summary. HHS Publication No. SMA 185063PT1. Rockville, MD Substance Abuse and Mental Health Services Administration, 2018.